Recent progress in laboratory diagnosis of thalassemia and hemoglobinopathy: a study by the Korean Red Blood Cell Disorder Working Party of the Korean Society of Hematology
来源期刊:Blood researchDOI:10.5045/br.2019.54.1.17
Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study
来源期刊:Blood researchDOI:10.5045/br.2019.54.3.175
Biphenotypic acute leukemia or acute leukemia of ambiguous lineage in childhood: clinical characteristics and outcome
来源期刊:Blood researchDOI:10.5045/br.2019.54.1.63
Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts
来源期刊:Blood researchDOI:10.5045/br.2019.54.3.165
ABCB1 and BMI1 mRNA expression in patients with chronic myeloid leukemia: impact on imatinib efficacy
来源期刊:Blood researchDOI:10.5045/br.2019.54.1.57
Biochemical effects and safety of Gum arabic (Acacia Senegal) supplementation in patients with sickle cell anemia
来源期刊:Blood researchDOI:10.5045/br.2019.54.1.31
Treatment of autoimmune hemolytic anemia: real world data from a reference center in Mexico
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.131
The increasing trend of blood donation in Iran
来源期刊:Blood researchDOI:10.5045/br.2019.54.4.269
Potential biomarkers and antagonists for fluoranthene-induced cellular toxicity of bone marrow derived mesenchymal stem cells
来源期刊:Blood researchDOI:10.5045/br.2019.54.4.253
Molecular perspective of iron uptake, related diseases, and treatments
来源期刊:Blood researchDOI:10.5045/br.2019.54.1.10
Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.114
The top 10 things to know about transfusion medicine before intern year: an evidence-based course for graduating medical students
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.125
What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.153
Beta-2 microglobulin as a prognostic factor of primary central nervous system lymphoma
来源期刊:Blood researchDOI:10.5045/br.2019.54.4.285
Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma
来源期刊:Blood researchDOI:10.5045/br.2019.54.4.244
Clinical significance of T cell receptor excision circle (TREC) quantitation after allogenic HSCT
来源期刊:Blood researchDOI:10.5045/br.2019.54.4.274
Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura
来源期刊:Blood researchDOI:10.5045/br.2019.54.3.218
Clinical features and treatment outcomes of Hodgkin lymphoma: A retrospective review in a Malaysian tertiary hospital
来源期刊:Blood researchDOI:10.5045/br.2019.54.3.210
HIV/AIDS-related lymphoma: perspective from a regional cancer center in India
来源期刊:Blood researchDOI:10.5045/br.2019.54.3.181
Characteristics and survival of patients with atypical chronic myeloid leukemia
来源期刊:Blood researchDOI:10.5045/br.2019.54.3.233
Bone marrow metastasis of small cell lung carcinoma with spontaneous tumor lysis syndrome without hepatic metastasis at diagnosis: first case report in Korea and review of literature
来源期刊:Blood researchDOI:10.5045/br.2019.54.3.231
Analysis of hematologic parameters of donors, patients, and granulocyte concentrates to predict successful granulocyte transfusion
来源期刊:Blood researchDOI:10.5045/br.2019.54.1.52
Outcome and prognostic factors of children with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib followed by allogeneic hematopoietic cell transplantation in first remission
来源期刊:Blood researchDOI:10.5045/br.2019.54.1.45
Efficacy of parenteral glutamine supplementation in adult hematopoietic stem cell transplantation patients
来源期刊:Blood researchDOI:10.5045/br.2019.54.1.23
Microcytosis in children and adolescents with the sickle cell trait in Basra, Iraq
来源期刊:Blood researchDOI:10.5045/br.2019.54.1.38
Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib
来源期刊:Blood researchDOI:10.5045/br.2019.54.1.77
Evaluating the effect of donor anxiety levels and lifestyle characteristics on the activation of platelet concentrates
来源期刊:Blood researchDOI:10.5045/br.2019.54.4.262
EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
来源期刊:Blood researchDOI:10.5045/br.2019.54.4.282
Determining the risk factors associated with the development of Clostridium difficile infection in patients with hematological diseases
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.120
Erratum: Breast implant-associated anaplastic large cell lymphoma
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.157
Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.108
Comparison of quality of life and depression between hematopoietic stem cell transplantation survivors and their spouse caregivers
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.137
Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning
来源期刊:Blood researchDOI:10.5045/br.2019.54.4.290
Favorable long-term survival using consolidation chemotherapy without allogeneic hematopoietic cell transplantation for acute myeloid leukemia with wild-type NPM1 without FLT3-ITD
来源期刊:Blood researchDOI:10.5045/br.2019.54.3.189
The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A
来源期刊:Blood researchDOI:10.5045/br.2019.54.3.204
Successful treatment of non-IgM lymphoplasmacytic lymphoma by bortezomib-containing regimen: case reports and review of literature
来源期刊:Blood researchDOI:10.5045/br.2019.54.3.236
Subgroup analysis of a phase 2/3 study of rurioctocog alfa pegol in patients with severe hemophilia A: efficacy and safety in previously treated Korean patients
来源期刊:Blood researchDOI:10.5045/br.2019.54.3.198
Optimizing carfilzomib use in multiple myeloma treatment
来源期刊:Blood researchDOI:10.5045/br.2019.54.3.159
Organ-specific considerations for marginal zone lymphomas in Korea, based on Consortium for Improving Survival of Lymphoma (CISL) and Korean clinical studies
来源期刊:Blood researchDOI:10.5045/br.2019.54.1.4
A case of immune thrombocytopenia associated with invasive thymoma successfully treated with eltrombopag
来源期刊:Blood researchDOI:10.5045/br.2019.54.1.74
First case report of latent tuberculosis reactivation complicating treatment with nilotinib in chronic myeloid leukemia
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.151
Enhanced polo-like kinase 1 expression in myelodysplastic syndromes
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.102
Role of redox iron towards an increase in mortality among patients: a systemic review and meta-analysis
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.87
Erratum: Evaluation of thrombocytopenia in the hematology clinic: a case series from a large tertiary care center
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.158
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
来源期刊:Blood researchDOI:10.5045/br.2019.54.4.288
An investigation of methylation pattern changes in the IKZF1 promoter in patients with childhood B-cell acute lymphoblastic leukemia
来源期刊:Blood researchDOI:10.5045/br.2019.54.2.144